Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Nogueira Jorge — BioAge Labs, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Nogueira Jorge

Nogueira Jorge

Director at BioAge Labs, Inc. · on record since Nov 13, 2013
Director at BioAmber Inc. · on record since May 10, 2013

Insider trading activity of Nogueira Jorge

Transactions on record: 2; since Nov 13, 2013

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 14, 2014

Figures computed from official regulatory filings — methodology.

Companies where Nogueira Jorge has traded

BioAge Labs, Inc.2 tx · Feb 14, 2014

Track record of Nogueira Jorge

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Nogueira Jorge

Co-insiders of Nogueira Jorge

Ashworth Andrew P.BioAge Labs, Inc. +1
BRINER KURT WBioAge Labs, Inc. +1
CAMP WILLIAM HBioAge Labs, Inc. +1
Haller HeinzBioAge Labs, Inc. +1
Hartmann Michael A.BioAge Labs, Inc. +1
Huc Jean-FrancoisBioAge Labs, Inc. +1
LAND RAYMOND JBioAge Labs, Inc. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Lucquin DenisBioAge Labs, Inc. +1

Millis JamesBioAge Labs, Inc. +1

Pettersen BabetteBioAge Labs, Inc. +1

Wall Kenneth W.BioAge Labs, Inc. +1

Barton ShaneBioAge Labs, Inc.

Chen BihuaBioAge Labs, Inc.

Cormorant Asset Management, LPBioAge Labs, Inc.

Cormorant Private Healthcare Fund IV LPBioAge Labs, Inc.

Cormorant Private Healthcare Fund V LPBioAge Labs, Inc.

Davidson Michael H.BioAge Labs, Inc.

Eno Richard PBioAge Labs, Inc.

ENRIGHT PATRICK GBioAge Labs, Inc.

Fortney KristenBioAge Labs, Inc.

Frost RobertBioAge Labs, Inc.

GARNIER JEAN PIERREBioAge Labs, Inc.

GOLDSTEIN DOV A MDBioAge Labs, Inc.

Gosbee George Frederick JohnBioAge Labs, Inc.

HEALY JAMESBioAge Labs, Inc.

Hemrajani RekhaBioAge Labs, Inc.

Laurin FrancoisBioAge Labs, Inc.

LINSERT HENRY JRBioAge Labs, Inc.

MARTIN GEORGINABioAge Labs, Inc.

MCVP TECHNOLOGY FUND I, LLCBioAmber Inc.

MITSUI & CO LTDBioAmber Inc.

Morgen EricBioAge Labs, Inc.

Naxamber S.A.BioAmber Inc.

Naxos Capital Managers S.a r.l.BioAmber Inc.

Naxos Capital Partners SCA SICARBioAmber Inc.

Orecchioni FabriceBioAge Labs, Inc.

Pande Vijay SatyanandBioAge Labs, Inc.

RICHSTONE ELLEN BBioAge Labs, Inc.

RUBIN PAUL DBioAge Labs, Inc.

Saucier MarioBioAge Labs, Inc.

Settino MarioBioAge Labs, Inc.

SOFINNOVA CAPITAL VI FCPRBioAmber Inc.

Sofinnova Partners SASBioAmber Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
BioAge Labs, Inc.	Feb 14, 2014	AwardD	6,125	0.00 USD	$0	SEC
BioAge Labs, Inc.	Nov 13, 2013	AwardD	6,125	0.00 USD	$0	SEC